Endometrial cancer: predictors and oncological safety of tumor tissue manipulation
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Tauste, C
- Díaz-Feijoo, B
- Cabrera, S
- Oliver-Pérez, R
- Coronado, PJ
- Martín-Salamanca, MB
- Pantoja-Garrido, M
- Marcos-Sanmartin, J
- Cazorla, E
- Lorenzo, C
- Rodríguez-Hernández, JR
- Roldán-Rivas, F
- Gilabert-Estellés, J
- Muruzábal, JC
- SEGO Spain-GOG Grp
Grupos
Abstract
PurposeThe main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results.MethodsWe performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen.ResultsA total of 2852 women from 15 centers were included and divided into two groups based on the lympho-vascular status in the final surgical specimen: 2265 (79.4%) had no LVSI and 587 (20.6%) presented LVSI. The use of uterine manipulator was associated with higher chances of lympho-vascular involvement regardless of the type used: Balloon manipulator (HR: 95% CI 4.64 (2.99-7.33); p < 0.001) and No-Balloon manipulator ([HR]: 95% CI 2.54 (1.66-3.96); p < 0.001). There is no evidence of an association between the use of preoperative hysteroscopy and higher chances of lympho-vascular involvement (HR: 95% CI 0.90 (0.68-1.19); p = 0.479).ConclusionWhilst performing common gynecological procedures, iatrogenic distention and manipulation of the uterine cavity are produced. Our study suggests that the use of uterine manipulator increases the rate of LVSI and, therefore, leads to poorer oncological results. Conversely, preoperative hysteroscopy does not show higher rates of LVSI involvement in the final surgical specimen and can be safely used.
© 2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Datos de la publicación
- ISSN/ISSNe:
- 1699-048X, 1699-3055
- Tipo:
- Article
- Páginas:
- 1098-1105
- PubMed:
- 37668932
- Factor de Impacto:
- 0,764 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Clinical & Translational Oncology SPRINGER INT PUBL AG
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Keywords
- Endometrial cancer; Hysteroscopy; Uterine manipulator; Oncological outcomes
Campos de Estudio
Cita
QUINTANA R,PADILLA P,LAGO V,Tauste C,Díaz B,Cabrera S,Oliver R,Coronado PJ,Martín MB,Pantoja M,Marcos J,Cazorla E,Lorenzo C,Rodríguez JR,Roldán F,Gilabert J,Muruzábal JC,CAÑADA A,DOMINGO S,SEGO Spain GRP. Endometrial cancer: predictors and oncological safety of tumor tissue manipulation. Clin. Transl. Oncol. 2024. 26. (5):p. 1098-1105. IF:2,500. (3).
Portal de investigación